SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029125
Filing Date
2018-11-13
Accepted
2018-11-13 07:33:13
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001205922-10q_20180930.htm 10-Q 2351775
2 EX-31.1 ck0001205922-ex311_7.htm EX-31.1 21851
3 EX-31.2 ck0001205922-ex312_6.htm EX-31.2 21937
4 EX-32.1 ck0001205922-ex321_8.htm EX-32.1 12563
  Complete submission text file 0001564590-18-029125.txt   7058297

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ck0001205922-20180930.xml EX-101.INS 1303498
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001205922-20180930.xsd EX-101.SCH 53900
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001205922-20180930_cal.xml EX-101.CAL 44640
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001205922-20180930_def.xml EX-101.DEF 197821
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001205922-20180930_lab.xml EX-101.LAB 391684
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001205922-20180930_pre.xml EX-101.PRE 322113
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 181175127
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1